Compounds > 2-ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione
Page last updated: 2024-08-26

2-ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione and Dementia

2-ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione has been researched along with Dementia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Spiegel, R; Wettstein, A1
Ohtomo, E1

Reviews

1 review(s) available for 2-ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione and Dementia

ArticleYear
[Recent drug therapy of senile dementia].
    No to shinkei = Brain and nerve, 1987, Volume: 39, Issue:1

    Topics: Adrenocorticotropic Hormone; Alzheimer Disease; Choline; Dementia; Dihydroergotoxine; Humans; Narcotic Antagonists; Peptide Fragments; Phosphatidylcholines; Physostigmine; Piracetam; Pyrrolidines; Succinimides

1987

Trials

1 trial(s) available for 2-ethyl-8-methyl-2,8-diazaspiro(4,5)decane-1,3-dione and Dementia

ArticleYear
Clinical trials with the cholinergic drug RS 86 in Alzheimer's disease (AD) and senile dementia of the Alzheimer type (SDAT).
    Psychopharmacology, 1984, Volume: 84, Issue:4

    Topics: Aged; Alzheimer Disease; Clinical Trials as Topic; Dementia; Double-Blind Method; Female; Humans; Male; Parasympathomimetics; Random Allocation; Succinimides

1984